Growing Demand for Biosensors Market : Opportunities for Market Expansion


Posted February 22, 2023 by Prashantvi

The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026

 
The biosensors market is valued at USD 25.5 billion in 2021 and is projected to reach USD 36.7 billion by 2026; it is expected to grow at a CAGR of 7.5% from 2021 to 2026.

Emerging markets in developing countries, high-growth opportunities in the food industry and environmental monitoring applications, and high-growth opportunities in the wearable device market are projected to offer lucrative opportunities for the players operating in the biosensors market during the forecast period.

The biosensors market includes players like Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), and DuPont (US),. These players have a strong market presence for biosensors across various countries in North America, Europe, APAC, and RoW.



Download PDF Brochure @

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=798



Emerging Opportunities in the Biosensors Market



Increasing need for point-of-care testing : Biosensors offer the potential to enable rapid and precise testing for a variety of medical disorders, which is especially crucial for point-of-care testing in locations with limited access to standard laboratory facilities. This offers a big chance for biosensor producers to create tools that can provide quick findings in a range of circumstances.



Demand for wearable biosensors is rising as wearable technology becomes more popular, and these biosensors are needed to keep track of a variety of health factors in real-time. This offers a chance for biosensor makers to create small, lightweight, user-friendly devices that can wirelessly communicate data to other devices.



Biosensors are also being utilised more frequently for environmental monitoring applications, such as identifying contaminants in water and the atmosphere. This offers a chance for makers of biosensors to create tools that can monitor environmental conditions in real-time, assisting in the preservation of both the environment and public health.



Biosensors market in North America to hold the highest market share during the forecast period



North America is projected to account for the largest size of the global biosensors market from 2021 to 2026. The presence of key industrial players and the early adoption of new technological advancements such as nanotechnology are the main factors for the growth of the biosensors market in North America. The market’s growth is mostly driven by the rise in funding for the research and development of medical devices containing biosensors. Research and development of medical devices are largely dependent on funding and grants. For instance, in 2017, Senseonics Holdings (US), a medical technology company, raised USD 41 million to commercialize its Eversense continuous glucose monitoring system and to support research and development for next-generation versions of the sensor. Similarly, in 2016, Endotronix (US), a developer of wireless and implantable pressure sensors, raised USD 32 million in a series C round of financing. These investments resulted in the development of biosensors for a range of medical equipment and this drove the market during the historic period.



Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Cytiva (UK), Dexcom, Inc. (US), Lifescan IP Holdings, LLC (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), ACON Laboratories, Inc. (US), CARDEA BIO INC., (US), Conductive Technologies (US), EarlySense (Israel), Innovative Sensor Technology IST AG (Switzerland), LifeSignals (US), NeuroSky (US), Pinnacle Technology Inc. (US), SD Biosensor, INC. (South Korea), VitalConnect (US), and Xsensio (Switzerland) are a few of the key players in the biosensors market.

Know more @ https://www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html



About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ’GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country United States
Categories Electronics
Tags biosensors market
Last Updated February 22, 2023